Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.

Researchers have discovered in an ongoing phase IIb trial that a single intravitreal injection of UBX1325 (foselutoclax), a ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency.

In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study investigating OTX-TKI for the treatment of nonproliferative diabetic ...

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

In 2023, the FDA approved aflibercept 8 mg for wet AMD, DME, and diabetic retinopathy ... to return within 4 days of treatment after injection, Charbel Issa and team said. "Mild, self-limiting ...

In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...